EP 1084236 A1 20010321 - NOVEL ADENOVIRAL VECTORS FOR GENE THERAPY
Title (en)
NOVEL ADENOVIRAL VECTORS FOR GENE THERAPY
Title (de)
ADENOVIRALE VEKTOREN FÜR DIE GENTHERAPY
Title (fr)
NOUVEAUX VECTEURS ADENOVIRAUX UTILISES EN THERAPIE GENIQUE
Publication
Application
Priority
- US 9912548 W 19990604
- US 8860598 P 19980609
- US 9725898 P 19980820
Abstract (en)
[origin: WO9964577A1] Helper dependent adenoviral vectors are suitable for use in gene therapy, as they are stable, contain only a very small amount less than about 0.5 % of helper virus contamination, and are less immunogenic than previous adenoviral vectors. The only viral DNA in the vectors are ITRs and packaging signals, and overall size is about 26-38 kb.
IPC 1-7
IPC 8 full level
A61K 35/76 (2006.01); A61K 38/22 (2006.01); A61K 48/00 (2006.01); C07K 14/575 (2006.01); C12N 5/10 (2006.01); C12N 7/00 (2006.01); C12N 15/09 (2006.01); C12N 15/861 (2006.01)
CPC (source: EP)
A61K 38/2264 (2013.01); C07K 14/5759 (2013.01); C12N 15/86 (2013.01); A61K 48/00 (2013.01); C12N 2710/10343 (2013.01); C12N 2800/30 (2013.01); C12N 2830/38 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9964577 A1 19991216; CA 2329947 A1 19991216; EP 1084236 A1 20010321; EP 1084236 A4 20030402; JP 2002517234 A 20020618
DOCDB simple family (application)
US 9912548 W 19990604; CA 2329947 A 19990604; EP 99927250 A 19990604; JP 2000553567 A 19990604